期刊文献+

蚌埠地区2009-2010年抗菌药物致不良反应报告分析 被引量:8

Analysis of Antibiotics-induced Adverse Drug Reactions in Bengbu Area from 2009 to 2010
原文传递
导出
摘要 目的:了解蚌埠地区抗菌药物致不良反应(ADR)的发生情况。方法:对2009-2010年蚌埠地区上报的抗菌药物致ADR报告,按性别、年龄、给药途径、药品类别、ADR累及器官或系统及临床表现等进行统计、分析。结果:ADR涉及的抗菌药物共107种,2791例/次,发生频次以头孢菌素类居首位(占31.31%),其次为喹诺酮类和青霉素类;主要的ADR类型为皮肤及其附件损害,占40.58%;严重ADR11例。结论:临床应规范抗菌药物的临床应用,以减少其ADR的发生率。 OBJECTIVE: To investigate the situation of antibiotics-induced adverse drug reactions (ADR) in Bengbu area. METHODS: According to gender, age, route of administration, drug category, organs or systems involved in ADR, clinical manifestations, and so on, reports of antibiotics-induced drug adverse reactions reported in Bengbu from 2009 to 2010 were analyzed statistically. RESULTS: 107 antibiotics were involved in ADR for 2 791 times. ADR most occurred in cephalosporin antibiotics (31.31% ), followed by quinolones and penicillins. Primary ADR type was lesion of skin and its appendents, which accounted for 40.58% of the total. 11 cases suffered from serious ADR. CONCLUSIONS: Clinical application of antibiotics should be standardized to reduce the incidence of ADR.
出处 《中国药房》 CAS CSCD 2012年第2期150-152,共3页 China Pharmacy
基金 2010年蚌埠市医疗卫生科技计划项目(201003022)
关键词 抗菌药物 药品不良反应 联合用药 合理用药 Antibiotics ADR Drug combination Rational drug use
  • 相关文献

参考文献7

二级参考文献26

  • 1汪晓燕,徐向阳,胡军高.对717例药品不良反应监测报告的分析[J].中国药房,1994,5(5):28-30. 被引量:11
  • 2YANG Jing QIAO Hai-ling ZHANG Yue-wen JIA Linojing TIAN Xin GAO Na.HLA-DRB genotype and specific IgE responses in patients with allergies to penicillins[J].Chinese Medical Journal,2006(6):458-466. 被引量:3
  • 3Sachs B, Riegel S, Seebeck J, et al. El anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluor- oquinolones and occurrence after first-ever use [J].Drug Saf, 2006,29 (11): 1087-1100.
  • 4Kang J S,Wang L,Chen X L,et al. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG[J].Mol Pharmacol, 2001,59(1): 122.
  • 580 Postmarketing reporting of adverse experiences [ R ]. The Code of Federal Regulations, FDA, USA ,21CFR600:80 See ,600.
  • 680 Postmarketing reporting of adverse drug experiences [ R 1. The Code of Federal Regulations, FDA, USA,21 C FR314,80 Sec :314.
  • 7Guidance for Industry, Pharmacovigilance of Veterinary Medicinal Products. Management of Periodic Summary Update Reports (PSUs) [R]. VICH GL29, USA.
  • 8Guidance for Industry, Postmarketing Safety Reporting for Human Drug and Biological, Products Including Vac 2 cines [ R ]. FDA, USA.
  • 9Prescription Drug User Fee Act of 1992 (PDUFA), http://www. fda. gov/cder/pdufa/default, htm,访问时间:2008年6月11日.
  • 10Prescription Drug User Fee Amendments of 2002, http ://www. fda. gov/cder/pdufa/default, htm, 访问时间:2008年6月11日.

共引文献136

同被引文献53

  • 1周超凡.中药注射剂不良反应的警示[J].中国药物警戒,2005,2(2):65-68. 被引量:109
  • 2刘继斌,曲成毅,王瑞花.基于属性AHM的Topsis综合评价及其应用[J].现代预防医学,2006,33(10):1862-1863. 被引量:47
  • 3卫生部,国家中医药管理局,总后卫生部.抗菌药物临床应用指导原则[s].卫发[2004]285号.
  • 4卫生部.药品不良反应报告和监测管理办法[S].2011.
  • 5陈新谦 金有豫 汤光.新编药物学[M]15版[M].北京:人民卫生出版社,2003.583.
  • 6Passarelli MC,Jaeob-Filho W,Figueras A. Adverse Drug Reac- tions in an Elderly Hospitalised Population[J].Drugs&Aging, 2005,22(9) :767-777.
  • 7Gallagher LP. The Potential for Adverse Drug Reaetions in an Elderly Patients[J]. Applied Nursing Researeh, 2001,14 (4) : 220.
  • 8Davies EC, Grecn CF, Taylor S, et al. Adverse drug reac- tions in hospital in-patients: a prospective analysis of 3695 patient-episodes [ J ]. PLoS One, 2009, 4 ( 2 ) : e4439 A, A, A, 5.
  • 9Noblat AC, Noblat LA, de Toledo LA, et 8.1. Prevalence of hospital admission due to adverse drug reaction in Salva- dor,bahia[J]. Rev Assoc Med Bras,2011,57 ( 1 ) :42- 45.
  • 10Gallagher RM,Bird KA,Mason JR,et al.Adverse drug reactionscausing admission to a pediatric hospital:a pilot study[J].J Clin Pharm Ther,2011,36(2):194.

引证文献8

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部